Compounds > atenolol
Page last updated: 2024-10-23

atenolol and Kidney Failure

atenolol has been researched along with Kidney Failure in 9 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.

Research Excerpts

ExcerptRelevanceReference
" We designed a study investigating the effect of enalapril on the protection of renal function in autosomal dominant polycystic kidney disease (ADPKD)."5.10No effect of enalapril on progression in autosomal dominant polycystic kidney disease. ( Breuning, MH; Duiser, R; van Dijk, MA; van Es, LA; Westendorp, RG, 2003)
"Hypertension was induced by oral administration of nitric oxide synthase inhibitor, N-nitro L-arginine-methyl-ester (L-NAME), at 40 mg/kg body weight to the male Wistar rats for 14 consecutive days."1.51Taurine Ameliorates Thyroid Hypofunction and Renal Injury in L-NAME-Induced Hypertensive Rats. ( Adedara, IA; Adeyemo, MO; Ajibade, TO; Alake, SE; Farombi, EO; Olajide, LO, 2019)
" Recently a new method has been proposed to determine absolute bioavailability in the absence of intravenous dose."1.30Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical view. ( Mahmood, I, 1997)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's3 (33.33)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adedara, IA1
Alake, SE1
Olajide, LO1
Adeyemo, MO1
Ajibade, TO1
Farombi, EO1
Rodenas, M1
Kumar, S1
Freund, KB1
Moallem, J1
Huang, SH1
Tirona, RG1
Ross, C1
Suri, RS1
van Dijk, MA1
Breuning, MH1
Duiser, R1
van Es, LA1
Westendorp, RG1
Williams, B1
Lacy, PS1
Thom, SM1
Cruickshank, K1
Stanton, A1
Collier, D1
Hughes, AD1
Thurston, H1
O'Rourke, M1
Baumgart, P1
el-Yazigi, A1
Bouchama, A1
al-Abdely, H1
Yusuf, A1
Sieck, JO1
Ruilope, LM1
Araque, A1
Lahera, V1
Suarez, C1
Mahmood, I1

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Improving Outcomes in Atrial Fibrillation Patients Aided by Implantable Cardiac Monitor: Evaluation of Chronic Beta-blocker Use Versus As-needed Pharmacological Rate Control[NCT05745337]Phase 120 participants (Anticipated)Interventional2023-02-06Recruiting
A Randomized, Open-label Study Investigating the Effect of Bilateral Renal Artery Sympathetic Denervation by Catheter-based Radiofrequency Ablation on Blood Pressure and Disease Progression in Autosomal Dominant Polycystic Kidney Disease[NCT01932450]Phase 2100 participants (Anticipated)Interventional2013-08-31Recruiting
Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)[NCT02584439]Phase 330 participants (Anticipated)Interventional2015-10-31Recruiting
Pulse Wave Velocity as a Predictor for Postoperative Cardiovascular Events[NCT03223441]543 participants (Actual)Observational2015-06-30Completed
Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol[NCT02403349]Phase 4105 participants (Actual)Interventional2012-05-31Active, not recruiting
Longitudinal Change of Arterial Stiffness Indices in Relation to Ambulatory Aortic and Branchial Pressure in Long Term Peritoneal Dialysis Patients[NCT03607747]40 participants (Anticipated)Observational2018-07-18Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

3 trials available for atenolol and Kidney Failure

ArticleYear
No effect of enalapril on progression in autosomal dominant polycystic kidney disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:11

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Double-Blind

2003
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Art

2006
Antihypertensive effect of nitrendipine in the hypertensive patient with renal impairment.
    Renal failure, 1993, Volume: 15, Issue:3

    Topics: Adult; Atenolol; Diuretics; Female; Follow-Up Studies; Humans; Hypertension; Hypertension, Renal; Ma

1993

Other Studies

6 other studies available for atenolol and Kidney Failure

ArticleYear
Taurine Ameliorates Thyroid Hypofunction and Renal Injury in L-NAME-Induced Hypertensive Rats.
    Drug research, 2019, Volume: 69, Issue:2

    Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Dietary Supplements; Disease Models, Ani

2019
Retinitis preceding systemic lupus erythematosus in absence of anti-phospholipid antibodies.
    International journal of rheumatic diseases, 2012, Volume: 15, Issue:2

    Topics: Adolescent; Antibodies, Antiphospholipid; Atenolol; Cyclophosphamide; Diagnosis, Differential; Drug

2012
Case report: atenolol overdose successfully treated with hemodialysis.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2013, Volume: 17, Issue:4

    Topics: Atenolol; Drug Overdose; Humans; Male; Middle Aged; Renal Dialysis; Renal Insufficiency

2013
[Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    MMW Fortschritte der Medizin, 2008, Jan-17, Volume: 150, Issue:1-2

    Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme

2008
Impaired elimination of atenolol in a nephropathic patient with self-medication overdose.
    Journal of clinical pharmacology, 1993, Volume: 33, Issue:5

    Topics: Atenolol; Diabetes Mellitus, Type 2; Drug Overdose; Female; Humans; Hypertension; Metabolic Clearanc

1993
Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical view.
    Biopharmaceutics & drug disposition, 1997, Volume: 18, Issue:6

    Topics: Acebutolol; Administration, Oral; Adult; Aged; Amiloride; Anti-Arrhythmia Agents; Anti-Infective Age

1997